loading...| Preferred Name |
Hydrazine Sulfate |
|
| Synonyms |
|
|
| Definitions |
The synthetic sulfate salt of hydrazine, a derivative of ammonia. Hydrazine inhibits the enzyme phosphoenol pyruvate carboxykinase, thereby blocking gluconeogenesis. This agent has been reported to decrease the excessive energy needs and cachexia of cancer patients. Classified as a likely human carcinogen, hydrazine sulfate is also a weak inhibitor of mono-amine oxidase (MAO). (NCI04) |
|
| ID |
http://purl.obolibrary.org/obo/NCIT_C1129 |
|
| ALT_DEFINITION |
A substance that has been studied as a treatment for cancer and as a treatment for cachexia (body wasting) associated with advanced cancer. |
|
| CAS_Registry |
10034-93-2 |
|
| Chemical_Formula |
H2O4S.H4N2 |
|
| code |
C1129 |
|
| Contributing_Source |
FDA |
|
| definition |
The synthetic sulfate salt of hydrazine, a derivative of ammonia. Hydrazine inhibits the enzyme phosphoenol pyruvate carboxykinase, thereby blocking gluconeogenesis. This agent has been reported to decrease the excessive energy needs and cachexia of cancer patients. Classified as a likely human carcinogen, hydrazine sulfate is also a weak inhibitor of mono-amine oxidase (MAO). (NCI04) |
|
| FDA_UNII_Code |
1N369SAT01 |
|
| Has_Free_Acid_Or_Base_Form | ||
| in_subset | ||
| label |
Hydrazine Sulfate |
|
| Legacy Concept Name |
Hydrazine_Sulfate |
|
| NCI_Drug_Dictionary_ID |
40141 |
|
| NSC Number |
150014 215190 |
|
| PDQ_Closed_Trial_Search_ID |
40141 |
|
| PDQ_Open_Trial_Search_ID |
40141 |
|
| Preferred_Name |
Hydrazine Sulfate |
|
| prefixIRI |
NCIT:C1129 |
|
| prefLabel |
Hydrazine Sulfate |
|
| Semantic_Type |
Organic Chemical Pharmacologic Substance |
|
| UMLS_CUI |
C0063067 |
|
| subClassOf |